DR. CAIN EDWARD DIMON M.D.
Prescription History 1437196839
Anesthesiology - Pain Medicine in Royal Oak, MI

NPI Status: Active since June 02, 2006

Contact Information

3601 W 13 MILE RD
ROYAL OAK, MI
ZIP 48073
Phone: (248) 898-1905
Fax: (248) 898-1032

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CAIN EDWARD DIMON M.D., an active Pain Medicine specialist practicing in Royal Oak, MI. Our medical registry currently tracks 26 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,274 documented patient claims. Among these therapy options, the most frequently utilized medication is Oxycodone Hcl, which accounts for 165 claims alone.


Baclofen

Generic Formulation: BaclofenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 30
30-Day Fills 52.3
Days Supply 1,520
MI State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills50.6
Peer Average Days Supply1,413
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $721.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.05

State Avg Cost Per Claim

$30.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Buprenorphine Hcl

Generic Formulation: Buprenorphine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 493
MI State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills41.7
Peer Average Days Supply1,119
Conservative Utilization

This provider writes prescriptions for this formulation 45.0% less frequently than the standard regional baseline metric for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $760.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$34.59

State Avg Cost Per Claim

$59.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

Therapeutic Applications

Buprenorphine is used to help relieve severe ongoing pain. Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Celecoxib

Generic Formulation: CelecoxibSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 65
30-Day Fills 87.0
Days Supply 2,610
MI State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills58.2
Peer Average Days Supply1,709
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 103.1% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,875.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$44.24

State Avg Cost Per Claim

$53.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

Therapeutic Applications

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 38
30-Day Fills 54.0
Days Supply 1,580
MI State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills46.0
Peer Average Days Supply1,201
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $693.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.24

State Avg Cost Per Claim

$13.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 482
MI State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills47.3
Peer Average Days Supply1,136
Conservative Utilization

This provider writes prescriptions for this formulation 40.0% less frequently than the standard regional baseline metric for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $545.23 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.72

State Avg Cost Per Claim

$35.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 83
30-Day Fills 174.0
Days Supply 5,198
MI State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills93.6
Peer Average Days Supply2,765
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 66.0% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,962.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.69

State Avg Cost Per Claim

$46.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Etodolac Er

Generic Formulation: EtodolacSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 14
30-Day Fills 16.0
Days Supply 480
MI State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills17.3
Peer Average Days Supply517
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,006.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$71.91

State Avg Cost Per Claim

$108.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).

Therapeutic Applications

See also Warning section. Etodolac is used to relieve pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Fentanyl

Generic Formulation: FentanylSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 630
MI State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills31.0
Peer Average Days Supply834
Conservative Utilization

This provider writes prescriptions for this formulation 30.0% less frequently than the standard regional baseline metric for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,988.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$94.68

State Avg Cost Per Claim

$100.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to cancer). Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Gabapentin

Generic Formulation: GabapentinSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 112
30-Day Fills 180.5
Days Supply 5,317
MI State Average Benchmarks
Peer Average Claims87.0
Peer Average 30-Day Fills124.3
Peer Average Days Supply3,567
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 28.7% more claims than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,307.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.53

State Avg Cost Per Claim

$20.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 60
30-Day Fills 60.0
Days Supply 1,546
MI State Average Benchmarks
Peer Average Claims94.0
Peer Average 30-Day Fills95.2
Peer Average Days Supply2,065
Conservative Utilization

This provider writes prescriptions for this formulation 36.2% less frequently than the standard regional baseline metric for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,982.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$33.04

State Avg Cost Per Claim

$19.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Hydromorphone Hcl

Generic Formulation: Hydromorphone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 76
30-Day Fills 76.0
Days Supply 2,085
MI State Average Benchmarks
Peer Average Claims66.0
Peer Average 30-Day Fills66.0
Peer Average Days Supply233
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,833.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.13

State Avg Cost Per Claim

$121.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Hydromorphone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 15
30-Day Fills 31.5
Days Supply 945
MI State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills82.7
Peer Average Days Supply2,445
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 67.4% less volume than the regional standard for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $181.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.10

State Avg Cost Per Claim

$6.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methadone Hcl

Generic Formulation: Methadone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 45
30-Day Fills 45.0
Days Supply 1,313
MI State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills34.6
Peer Average Days Supply957
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 32.4% more claims than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $882.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.60

State Avg Cost Per Claim

$20.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)

Therapeutic Applications

This medication is used to treat addiction to opioids (such as heroin) as part of an approved treatment program. Methadone belongs to a class of drugs known as opioid analgesics. It helps prevent withdrawal symptoms caused by stopping other opioids.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 44
30-Day Fills 50.2
Days Supply 1,329
MI State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills29.7
Peer Average Days Supply670
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 63.0% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $719.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.36

State Avg Cost Per Claim

$12.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Morphine Sulfate

Generic Formulation: Morphine SulfateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 261
MI State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.2
Peer Average Days Supply522
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.2% less volume than the regional standard for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $288.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.23

State Avg Cost Per Claim

$32.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Morphine Sulfate Er

Generic Formulation: Morphine SulfateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 317
MI State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills46.9
Peer Average Days Supply1,313
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.1% less volume than the regional standard for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $276.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.14

State Avg Cost Per Claim

$40.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Nortriptyline Hcl

Generic Formulation: Nortriptyline HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 25
30-Day Fills 35.0
Days Supply 1,050
MI State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills43.1
Peer Average Days Supply1,278
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $181.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.24

State Avg Cost Per Claim

$16.34

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters) in the brain.

Nucynta

Generic Formulation: Tapentadol HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 340
MI State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills14.9
Peer Average Days Supply415
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 50.0% more claims than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,262.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$536.32

State Avg Cost Per Claim

$972.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An opioid analgesic, MU OPIOID RECEPTOR agonist, and noradrenaline reuptake inhibitor that is used in the treatment of moderate to severe pain, and of pain associated with DIABETIC NEUROPATHIES.

Therapeutic Applications

Tapentadol is used to help relieve moderate to severe short-term pain (such as pain from an injury or after surgery). It belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 165
30-Day Fills 165.5
Days Supply 4,307
MI State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills41.3
Peer Average Days Supply733
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 302.4% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,000.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.24

State Avg Cost Per Claim

$21.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 50
30-Day Fills 50.3
Days Supply 1,323
MI State Average Benchmarks
Peer Average Claims62.0
Peer Average 30-Day Fills62.4
Peer Average Days Supply1,502
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,781.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.62

State Avg Cost Per Claim

$27.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Oxycontin

Generic Formulation: Oxycodone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 451
MI State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills25.3
Peer Average Days Supply687
Conservative Utilization

This provider writes prescriptions for this formulation 36.0% less frequently than the standard regional baseline metric for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,973.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$685.86

State Avg Cost Per Claim

$815.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to cancer). Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (more than 40 milligrams per tablet) should be used only if you have been regularly taking moderate to large amounts of an opioid pain medication. These strengths may cause overdose (even death) if taken by a person who has not been regularly taking opioids. Do not use the extended-release form of oxycodone to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Pregabalin

Generic Formulation: PregabalinSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 159
30-Day Fills 211.5
Days Supply 6,299
MI State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills52.5
Peer Average Days Supply1,510
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 287.8% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,333.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$33.55

State Avg Cost Per Claim

$45.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Savella

Generic Formulation: Milnacipran HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 450
MI State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills16.5
Peer Average Days Supply479
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,422.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$294.82

State Avg Cost Per Claim

$523.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA.

Therapeutic Applications

Milnacipran is used to treat pain caused by a condition called fibromyalgia that affects the muscles, tendons, ligaments, and supporting tissues. This medication is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 91
30-Day Fills 146.5
Days Supply 4,320
MI State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills49.6
Peer Average Days Supply1,324
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 127.5% higher than the standard regional baseline profile for MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,000.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.99

State Avg Cost Per Claim

$14.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Topiramate

Generic Formulation: TopiramateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 21
30-Day Fills 43.0
Days Supply 1,260
MI State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills54.4
Peer Average Days Supply1,594
Conservative Utilization

This provider writes prescriptions for this formulation 36.4% less frequently than the standard regional baseline metric for practitioners inside MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $331.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.79

State Avg Cost Per Claim

$19.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 40
30-Day Fills 41.0
Days Supply 1,034
MI State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills53.9
Peer Average Days Supply1,130
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $291.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.28

State Avg Cost Per Claim

$7.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. CAIN EDWARD DIMON M.D. provides transparency into local medical care patterns within Royal Oak, MI.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pain Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.